ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311,740 | +75.7% | 57,200 | +116.3% | 0.00% | +200.0% |
| Q2 2023 | $177,452 | +80.4% | 26,446 | +137.4% | 0.00% | 0.0% |
| Q1 2023 | $98,367 | -25.5% | 11,140 | -40.1% | 0.00% | 0.0% |
| Q3 2022 | $132,000 | -16.5% | 18,605 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $158,000 | -39.2% | 19,583 | +4.7% | 0.00% | -50.0% |
| Q1 2022 | $260,000 | -50.3% | 18,703 | +0.4% | 0.00% | -33.3% |
| Q4 2021 | $523,000 | -78.3% | 18,635 | -73.8% | 0.00% | -78.6% |
| Q3 2021 | $2,414,000 | -20.0% | 71,019 | -3.9% | 0.01% | -22.2% |
| Q2 2021 | $3,018,000 | +2.6% | 73,866 | +1.1% | 0.02% | -5.3% |
| Q1 2021 | $2,941,000 | -11.1% | 73,056 | +30.6% | 0.02% | -9.5% |
| Q4 2020 | $3,307,000 | – | 55,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |